Meeting
2022 ASCO Genitourinary Cancers Symposium
Association of nonseminomatous testicular germ cell tumors with teratoma-free primaries with disease relapse and overall survival.
Authors
Pia Paffenholz
Department of Urology and Uro-Oncology, University Hospital of Cologne, Cologne, Germany
Pia Paffenholz , Georg Landwehr , Christoph Alexander Seidel , Annika Poch , Richard Cathomas , David Pfister , Axel Heidenreich
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 422)
DOI
10.1200/JCO.2022.40.6_suppl.422
Abstract #
422
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2015 Genitourinary Cancers Symposium
A review of clinical stage 1 testicular cancer mortality in a high-volume center.
First Author: Sophia C. Kamran
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The effects of pre-existing psychiatric disorders on gastric cancer survival.
First Author: Josephine Soddano
Poster
2023 ASCO Annual Meeting
The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC without known EGFR mutations.
First Author: Jhanelle Elaine Gray
Poster
2023 ASCO Annual Meeting
Mortality among oncology patients with multiple unplanned hospital admissions.
First Author: Thomas J Roberts